These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16362154)

  • 1. ADPKD: molecular characterization and quest for treatment.
    Horie S
    Clin Exp Nephrol; 2005 Dec; 9(4):282-291. PubMed ID: 16362154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
    Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
    Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of ADPKD: the polycystin complex gets complex.
    Ong AC; Harris PC
    Kidney Int; 2005 Apr; 67(4):1234-47. PubMed ID: 15780076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].
    Torra R; Badenas C; Pérez-Oller L; San Millán JL; Tellería D; Estivill X; Darnell A
    Nefrologia; 2000; 20(1):39-46. PubMed ID: 10822721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of autosomal-dominant polycystic kidney disease.
    Gallagher AR; Hidaka S; Gretz N; Witzgall R
    Cell Mol Life Sci; 2002 Apr; 59(4):682-93. PubMed ID: 12022474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypes of autosomal dominant polycystic kidney disease in Japanese.
    Mizoguchi M; Tamura T; Yamaki A; Higashihara E; Shimizu Y
    J Hum Genet; 2002; 47(1):51-4. PubMed ID: 11829141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of kidney disease varies between families with defects in the polycystic kidney disease type 1 gene in eastern Finland.
    Lumiaho A; Ikäheimo R; Pihlajamäki J; Miettinen R; Niemitukia L; Vanninen R; Lampainen E; Laakso M
    Scand J Urol Nephrol; 2003; 37(4):352-8. PubMed ID: 12944197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical, genetic and molecular studies on autosomal dominant polycystic kidney disease].
    Torra R; Badenas C; Darnell A; Nicolau C; Volpini V; Revert L; Estivill X
    Med Clin (Barc); 1998 Apr; 110(13):481-7. PubMed ID: 9611728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
    Wu G; Somlo S
    Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKD1 interacts with PKD2 through a probable coiled-coil domain.
    Qian F; Germino FJ; Cai Y; Zhang X; Somlo S; Germino GG
    Nat Genet; 1997 Jun; 16(2):179-83. PubMed ID: 9171830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
    Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
    BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type identification of autosomal dominant polycystic kidney disease by analysis of fluorescent short tandem repeat markers.
    Lin WD; Wu JY; Tsai FJ; Gau MT; Lee CC
    J Formos Med Assoc; 2002 Aug; 101(8):567-71. PubMed ID: 12440087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant.
    Muto S; Aiba A; Saito Y; Nakao K; Nakamura K; Tomita K; Kitamura T; Kurabayashi M; Nagai R; Higashihara E; Harris PC; Katsuki M; Horie S
    Hum Mol Genet; 2002 Jul; 11(15):1731-42. PubMed ID: 12095915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of autosomal dominant polycystic kidney disease.
    Pei Y
    Clin Invest Med; 2003 Oct; 26(5):252-8. PubMed ID: 14596487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of cystic kidney diseases].
    Walz G
    Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the polycystins in kidney development.
    van Adelsberg JS
    Pediatr Nephrol; 1999 Jun; 13(5):454-9. PubMed ID: 10412869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell biology of polycystin-2.
    Tsiokas L; Kim S; Ong EC
    Cell Signal; 2007 Mar; 19(3):444-53. PubMed ID: 17084592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.